ALXO icon

ALX Oncology

96 hedge funds and large institutions have $622M invested in ALX Oncology in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

11% less funds holding

Funds holding: 10896 (-12)

20% less capital invested

Capital invested by funds: $780M → $622M (-$158M)

52% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 21

Holders
96
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$444K
Puts
$361K
Net Calls
Net Calls Change

Top Sellers

1 -$19.8M
2 -$15.5M
3 -$4.09M
4
Marshall Wace
Marshall Wace
United Kingdom
-$2.29M
5
Millennium Management
Millennium Management
New York
-$1.82M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$421K
52
$374K
53
$346K
54
$331K
55
$326K
56
$324K
57
$311K
58
$273K
59
$246K
60
$240K
61
$240K
62
$233K
63
$223K
64
$217K
65
$182K
66
$181K
67
$177K
68
$172K
69
$149K
70
$119K
71
$109K
72
$95K
73
$80K
74
$66K
75
$64K